IL89910A0 - Tp-receptor antagonists and compositions for modifying the action of myofibroblasts - Google Patents
Tp-receptor antagonists and compositions for modifying the action of myofibroblastsInfo
- Publication number
- IL89910A0 IL89910A0 IL89910A IL8991089A IL89910A0 IL 89910 A0 IL89910 A0 IL 89910A0 IL 89910 A IL89910 A IL 89910A IL 8991089 A IL8991089 A IL 8991089A IL 89910 A0 IL89910 A0 IL 89910A0
- Authority
- IL
- Israel
- Prior art keywords
- myofibroblasts
- modifying
- compositions
- action
- receptor antagonists
- Prior art date
Links
- 229940099508 TP receptor antagonist Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000000651 myofibroblast Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888808599A GB8808599D0 (en) | 1988-04-12 | 1988-04-12 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL89910A0 true IL89910A0 (en) | 1989-12-15 |
Family
ID=10635039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL89910A IL89910A0 (en) | 1988-04-12 | 1989-04-11 | Tp-receptor antagonists and compositions for modifying the action of myofibroblasts |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0337739A3 (fr) |
| JP (1) | JPH0228120A (fr) |
| KR (1) | KR890015743A (fr) |
| AU (1) | AU621598B2 (fr) |
| DK (1) | DK173789A (fr) |
| GB (1) | GB8808599D0 (fr) |
| IL (1) | IL89910A0 (fr) |
| PH (1) | PH26019A (fr) |
| ZA (1) | ZA892672B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2354708B (en) * | 1999-10-01 | 2004-06-02 | Johnson & Johnson Medical Ltd | Compositions for the treatment of wound contracture |
| WO2006046545A1 (fr) | 2004-10-26 | 2006-05-04 | Kyocera Corporation | Élément ondulé à surface élastique et dispositif de communication |
| JP2010516702A (ja) | 2007-01-18 | 2010-05-20 | エヴォルヴァ エスアー | 置換１，３−ジオキサンのプロドラッグおよびそれらの使用 |
| US20100273824A1 (en) | 2007-01-18 | 2010-10-28 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2127406B (en) * | 1982-09-16 | 1986-03-05 | Glaxo Group Ltd | Piperidinlycyclopentanolheptenoic acid salt |
-
1988
- 1988-04-12 GB GB888808599A patent/GB8808599D0/en active Pending
-
1989
- 1989-04-10 JP JP1088216A patent/JPH0228120A/ja active Pending
- 1989-04-11 EP EP19890303581 patent/EP0337739A3/fr not_active Withdrawn
- 1989-04-11 IL IL89910A patent/IL89910A0/xx unknown
- 1989-04-11 KR KR1019890004742A patent/KR890015743A/ko not_active Withdrawn
- 1989-04-11 DK DK173789A patent/DK173789A/da active IP Right Grant
- 1989-04-12 ZA ZA892672A patent/ZA892672B/xx unknown
- 1989-04-12 PH PH38487A patent/PH26019A/en unknown
- 1989-04-12 AU AU32754/89A patent/AU621598B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB8808599D0 (en) | 1988-05-11 |
| KR890015743A (ko) | 1989-11-25 |
| EP0337739A2 (fr) | 1989-10-18 |
| JPH0228120A (ja) | 1990-01-30 |
| ZA892672B (en) | 1990-04-25 |
| EP0337739A3 (fr) | 1990-10-10 |
| DK173789D0 (da) | 1989-04-11 |
| DK173789A (da) | 1989-10-13 |
| AU621598B2 (en) | 1992-03-19 |
| PH26019A (en) | 1992-01-29 |
| AU3275489A (en) | 1989-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR880100301A (en) | Plug suppliers and compositions for their construction | |
| IL92082A0 (en) | Compositions comprising resiniferatoxin and their use | |
| GB2221674B (en) | Cement compositions | |
| ZA891063B (en) | Aqueous detergent compositions and methods of forming them | |
| GB8716219D0 (en) | Perfume compositions | |
| ZA895186B (en) | Perfumery compositions | |
| IL85312A0 (en) | Improving the stability of pharmaceutical compositions | |
| GB2217603B (en) | Deodorizing composition | |
| GB2223488B (en) | Cement compositions | |
| EP0436111A3 (en) | Compositions of substituted homopoly-p-phenylenes and thermoplastics | |
| BG49522A1 (en) | Pharmaceutist composition accelarating the healing of mounds | |
| IL89910A0 (en) | Tp-receptor antagonists and compositions for modifying the action of myofibroblasts | |
| GB8827826D0 (en) | Cleansing compositions | |
| EP0193008A3 (en) | Cycloalkan-1-ol derivatives and perfume compositions comprising the same | |
| NZ211274A (en) | Vasopressin antagonists and pharmaceutical compositions | |
| GB8821186D0 (en) | Compositions of matter | |
| IL93901A0 (en) | Intranasal compositions for the administration of physo-stigmine and arecoline | |
| ZA897631B (en) | Soap compositions | |
| GB8819562D0 (en) | Spray composition | |
| YU36390A (en) | Biocidic compositions and their use | |
| GB8914344D0 (en) | Compounds and compositions | |
| IE882655L (en) | Cosmetic compositions | |
| ZA896902B (en) | Cosmetic compositions | |
| GB8713344D0 (en) | Perfume compositions | |
| GB8801772D0 (en) | Compositions of matter |